Markets:

Overview

News

Currencies

International

Treasuries

Glaukos Corporation Common Stock (NY:GKOS)

104.60 -1.18 (-1.12%)

Streaming Delayed Price Updated: 11:25 AM EDT, Mar 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Glaukos Corporation Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Where Glaukos Stands With Analysts ↗

December 12, 2022

Via Benzinga

Glaukos Announces Participation in the Stephens Annual Investment Conference

November 07, 2022

From Glaukos Corporation

Via Business Wire

Kellogg, Palo Alto Networks, Roku And Other Big Losers From Thursday ↗

November 04, 2022

U.S. stocks closed lower on Thursday, with the Dow Jones dropping more than 100 points. Here is the list of some big stocks recording losses in the previous session.

Via Benzinga

What 4 Analyst Ratings Have To Say About Glaukos ↗

November 03, 2022

Analysts have provided the following ratings for Glaukos (NYSE:GKOS) within the last quarter:

Via Benzinga

Needham Says Recent Launches To Drive Market Share Recovery For This Eye-Focused MedTech Stock ↗

October 04, 2022

Via Benzinga

Glaukos Shares Pop After Positive Data From Ocular Pressure Candidate ↗

September 07, 2022

Via Benzinga

Glaukos Inks Licensing Pact For Rare Eye Disorder Treatment ↗

August 24, 2022

Via Benzinga

Glaukos Corporation Announces Third Quarter 2022 Financial Results

November 02, 2022

From Glaukos Corporation

Via Business Wire

Glaukos to Release Third Quarter 2022 Financial Results after Market Close on November 2

October 12, 2022

From Glaukos Corporation

Via Business Wire

10 Health Care Stocks Whale Activity In Today's Session ↗

September 29, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2022 American Academy of Ophthalmology Annual Meeting

September 28, 2022

From Glaukos Corporation

Via Business Wire

Glaukos Receives FDA 510(k) Clearance For iStent infinite ↗

August 03, 2022

The U.S.

Via Benzinga

Why IMARA Jumped Around 75%; Here Are 54 Biggest Movers From Yesterday ↗

September 08, 2022

Gainers

Via Benzinga

Important Biotech Catalysts For September 7, 2022 - End Of The Day Summary ↗

September 07, 2022

Via Benzinga

Dow Jumps 450 Points; UiPath Shares Slide ↗

September 07, 2022

U.S. stocks traded higher toward the end of trading, with the Dow Jones adding around 450 points on Wednesday.

Via Benzinga

Dow Up 249 Points, Nasdaq Set To Snap Skid ↗

September 07, 2022

Stocks are charging higher this afternoon, though investors are still awaiting the release of the Federal Reserve's Beige Book.

Via Talk Markets

Why Korn Ferry Is Trading Lower By Over 8%, Here Are 40 Stocks Moving In Wednesday's Mid-Day Session ↗

September 07, 2022

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 64% to $0.1199. Allena Pharmaceuticals shares dipped over 30% on Tuesday after the company announced it has filed for bankruptcy.

Via Benzinga

Coupa Software, Glaukos And Some Other Big Stocks Moving Higher On Wednesday ↗

September 07, 2022

Via Benzinga

What's Going On With Glaukos Shares? ↗

September 07, 2022

Glaukos Corp (NYSE: GKOS) shares are trading higher by 1.87% to $49.00 Wednesday morning after the company announced topline data for both Phase 3 pivotal trials of iDose TR that successfully achieved...

Via Benzinga

Glaukos Announces Positive Topline Outcomes for Both Phase 3 Pivotal Trials of iDose TR, Achieving Primary Efficacy Endpoints and Demonstrating Favorable Tolerability and Safety Profiles

September 07, 2022

From Glaukos Corporation

Via Business Wire

Glaukos Announces More Than 1 Million iStent® Technologies Implanted Worldwide

September 06, 2022

From Glaukos Corporation

Via Business Wire

Glaukos Announces Participation in the Wells Fargo Healthcare Conference

August 24, 2022

From Glaukos Corporation

Via Business Wire

Glaukos Stock Scores Rising Price Performance With Jump To 91 RS Rating ↗

August 16, 2022

On Tuesday, Glaukos stock hit an key technical milestone, with its Relative Strength Rating climbing to 91, up from 87 the day before.

Via Investor's Business Daily

Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary ↗

August 03, 2022

Via Benzinga

Glaukos: Q2 Earnings Insights ↗

August 03, 2022

Glaukos (NYSE:GKOS) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Glaukos missed estimated earnings by...

Via Benzinga

Glaukos Announces FDA 510(k) Clearance of iStent infinite®

August 03, 2022

From Glaukos Corporation

Via Business Wire

Glaukos Corporation Announces Second Quarter 2022 Financial Results

August 03, 2022

From Glaukos Corporation

Via Business Wire

Glaukos to Release Second Quarter 2022 Financial Results after Market Close on August 3

July 13, 2022

From Glaukos Corporation

Via Business Wire

The 6 Most Aggressive Growth Stocks to Buy in July ↗

July 12, 2022

These are the 6 most aggressive growth stocks to buy in July. They reflect huge potential growth in their sales and/or their earnings.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For July 12, 2022 ↗

July 12, 2022

Upgrades

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.